TP53 mutations in human cancer: database reassessment and prospects for the next decade.
about
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadHuman cancer databases (review).p53 binding to human genome: crowd control navigation in chromatin contextDevelopment and characterization of six new human papillary thyroid carcinoma cell lines.Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.Genetic Variations in the TP53 Pathway in Native Americans Strongly Suggest Adaptation to the High Altitudes of the Andes.Expression screening using a Medaka cDNA library identifies evolutionarily conserved regulators of the p53/Mdm2 pathwayPCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas.A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene SilencingTowards Increasing the Clinical Relevance of In Silico Methods to Predict Pathogenic Missense VariantsCHEMICAL SELECTIVITY OF NUCLEOBASE ADDUCTION RELATIVE TO IN VIVO MUTATION SITES ON EXON 7 FRAGMENT OF P53 TUMOR SUPPRESSOR GENETP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythrodermaTargeted exome sequencing profiles genetic alterations in leiomyosarcoma.Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples.TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates.Recommendations for analyzing and reporting TP53 gene variants in the high-throughput sequencing era.The TP53 gene network in a postgenomic era.How the environment shapes cancer genomes.TP53: an oncogene in disguise.The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma.Cancer-Related Triplets of mRNA-lncRNA-miRNA Revealed by Integrative Network in Uterine Corpus Endometrial Carcinoma.A group of novel HIF-1α inhibitors, glyceollins, blocks HIF-1α synthesis and decreases its stability via inhibition of the PI3K/AKT/mTOR pathway and Hsp90 binding.TP53 Mutations in Breast and Ovarian Cancer.Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axisDetection of p53 Mutations in Circulating DNA of Transplanted Hepatocellular Carcinoma Patients as a Biomarker of Tumor Recurrence.Genetic profiling of CLL: a 'TP53 addict' perspective.The Putative Role of TP53 Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review.p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53.p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy.The rare nonsense mutation in p53 triggers alternative splicing to produce a protein capable of inducing apoptosis.Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome.Remote intracranial recurrence of IDH mutant gliomas is associated with TP53 mutations and an 8q gain.Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.Natural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in Cancer.miR-300 regulates cellular radiosensitivity through targeting p53 and apaf1 in human lung cancer cells.
P2860
Q28397132-A6A7710F-370E-4D4B-8CB8-C0B918B55B47Q34626088-173822D5-EA3C-4D29-AAA3-455DCEC5F6BBQ34755812-93DB3FEA-6E36-4084-8484-B83BA89256F2Q35055107-8531F1CA-12BD-4ED2-835D-905AD02B36C2Q35407284-01100B5D-A753-4EAF-BDE5-6347496CFF6BQ35779746-973D0A20-2106-44C1-82A3-875371810FCDQ35801225-AED9E377-1E8D-47F0-BA0C-5F00F7C5E931Q35838374-27C914AF-1E0F-4FB4-A7FA-7F9281840247Q35913035-F2CD8B78-7FA9-4D68-975F-CE1063F66341Q36015435-7ED250AF-F370-468B-A48F-96FB6BF9F1EBQ36093540-1DAD5FAF-AF45-400F-9702-8D79D666489DQ36310531-C026DCB8-30ED-4CD4-8820-7BA4C1AB5A67Q36470353-6E52B017-01DD-4F0B-A7EA-7FC909015A39Q36627211-437FEB7B-768B-454E-99FE-74C00384E91FQ36825602-8C564965-6F5A-42EF-B0F5-3FF6FCA1F7B6Q37381834-0904C064-DBE8-423B-AECF-D215F9F5DF99Q37645066-086A9948-3A6D-4775-83AC-CA41B03755EBQ37742485-A2834430-FB44-4E90-BD7A-1BC6EE799084Q38204360-98A95EF5-17EC-4450-9596-B7D09D3946C1Q38206172-30470109-E6EF-4EC1-A3B7-B1FBC82FCDA4Q38268784-F4D307B7-F44F-4D91-A47A-79AD481C7360Q38507513-26E53F83-6CA9-4388-A33E-556B9CA45B76Q38829089-E581DC1D-5145-4058-BCE1-E8739AA4BA8FQ38915810-5A9A6122-48BC-4F97-B804-6E204E1C7F4EQ38958096-9EDFFF0A-576A-4451-899C-12710C80D630Q38999130-2864D192-D7DE-4721-8229-3FC611C5BD75Q39176356-B738D6C7-DB23-47BA-B541-0ACDBB471F12Q39278937-361CCD77-FC0A-4394-B101-3CF3816CD32FQ39745194-A9A69AFB-BA37-4402-9BA0-AA77C39F975FQ41721833-2B54429E-2732-4B21-8F4C-FE61F18BD128Q41841346-535855FC-7FB5-40A0-B6E2-14E23704B0C8Q41924608-6E5F8017-5392-4C9F-8582-896487FDC5F4Q42321597-1107183A-A979-4DFB-BA2D-6B8D2A991C74Q42367544-6DF57BE8-3975-4DA3-B6BA-D103C0A37A81Q42775929-D81F01BB-0FDE-4414-9605-9394B99307FEQ45058556-B69ABFE7-49DE-410B-9D5D-266FE1539A76Q47339574-7B0C96D0-53EE-4D16-AD5F-A514B103BA29Q47564553-B808CAA2-1EA4-4F90-AD77-B4BDBA93D6B6Q47673940-A7BB226F-282F-4A11-8A57-D3721AB78DF8Q47818301-E80073B1-9A00-4DEB-A5CF-E4257EB7D271
P2860
TP53 mutations in human cancer: database reassessment and prospects for the next decade.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
TP53 mutations in human cancer: database reassessment and prospects for the next decade.
@en
type
label
TP53 mutations in human cancer: database reassessment and prospects for the next decade.
@en
prefLabel
TP53 mutations in human cancer: database reassessment and prospects for the next decade.
@en
P2860
P356
P1433
P1476
TP53 mutations in human cancer: database reassessment and prospects for the next decade.
@en
P2093
Bernard Leroy
Martha Anderson
P2860
P304
P356
10.1002/HUMU.22552
P577
2014-06-01T00:00:00Z